These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 15314975
1. Expression of p21 and bcl-2 proteins in paraffin-embedded preparations of non-small cell lung cancer in stage IIIA after Etoposide and Cisplatin induced chemotherapy. Mańdziuk S, Dudzisz-Sledź M, Korszeń-Pilecka I, Milanowski J, Wojcierowski J, Korobowicz E. Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):149-53. PubMed ID: 15314975 [Abstract] [Full Text] [Related]
2. Expression of p53 gene in stage IIIA non-small cell lung cancer in patients after neoadjuvant chemotherapy with Vepesid and Cisplatin. Mańdziuk S, Dudzisz-Sledź M, Korszeń-Pilecka I, Milanowski J, Wojcierowski J, Korobowicz E. Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):154-7. PubMed ID: 15314976 [Abstract] [Full Text] [Related]
3. Vascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer. Ludovini V, Gregorc V, Pistola L, Mihaylova Z, Floriani I, Darwish S, Stracci F, Tofanetti FR, Ferraldeschi M, Di Carlo L, Ragusa M, Daddi G, Tonato M. Lung Cancer; 2004 Oct; 46(1):77-85. PubMed ID: 15364135 [Abstract] [Full Text] [Related]
6. Expression of bcl-2, p53, and p21 in benign and malignant prostatic tissue before and after radiation therapy. Rakozy C, Grignon DJ, Sarkar FH, Sakr WA, Littrup P, Forman J. Mod Pathol; 1998 Sep; 11(9):892-9. PubMed ID: 9758370 [Abstract] [Full Text] [Related]
7. Prognostic significance of p21 protein expression in patients with pulmonary squamous cell carcinoma following induction chemotherapy. Tamura M, Sawabata N, Kobayashi S, Umezu H, Seki N, Yoshii N, Karube Y, Araki O, Ishihama H, Nagai S, Miyoshi S. Ann Thorac Cardiovasc Surg; 2007 Feb; 13(1):9-14. PubMed ID: 17392664 [Abstract] [Full Text] [Related]
8. Expression of PCNA in non-small cell lung cancer before and after treatment with cisplatin and vepeside. Zdunek M, Korobowicz E. Pol J Pathol; 2000 Feb; 51(2):77-81. PubMed ID: 10974930 [Abstract] [Full Text] [Related]
9. Defects in apoptotic signal transduction in cisplatin-resistant non-small cell lung cancer cells. Ikuta K, Takemura K, Kihara M, Naito S, Lee E, Shimizu E, Yamauchi A. Oncol Rep; 2005 Jun; 13(6):1229-34. PubMed ID: 15870947 [Abstract] [Full Text] [Related]
10. [The evaluation of prognostic value of cyclin B1 expression in patients with resected non-small-cell lung cancer stage I-IIIA--preliminary report]. Kosacka M, Korzeniewska A, Jankowska R. Pol Merkur Lekarski; 2010 Feb; 28(164):117-21. PubMed ID: 20369739 [Abstract] [Full Text] [Related]
11. Bax, bcl-2 and c-kit expression in non-small-cell lung cancer and their effects on prognosis. Yaren A, Oztop I, Kargi A, Ulukus C, Onen A, Sanli A, Binicier O, Yilmaz U, Alakavuklar M. Int J Clin Pract; 2006 Jun; 60(6):675-82. PubMed ID: 16805752 [Abstract] [Full Text] [Related]
12. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer. Mohamed S, Yasufuku K, Hiroshima K, Nakajima T, Yoshida S, Suzuki M, Sekine Y, Shibuya K, Iizasa T, Farouk A, Fujisawa T. Cancer; 2007 Jun 15; 109(12):2506-14. PubMed ID: 17487846 [Abstract] [Full Text] [Related]
13. Predictors of response to chemo-radiotherapy and radiotherapy for esophageal squamous cell carcinoma. Miyazaki T, Kato H, Faried A, Sohda M, Nakajima M, Fukai Y, Masuda N, Manda R, Fukuchi M, Ojima H, Tsukada K, Kuwano H. Anticancer Res; 2005 Jun 15; 25(4):2749-55. PubMed ID: 16080521 [Abstract] [Full Text] [Related]
15. Curcumin sensitizes lung cancer cells to cisplatin-induced apoptosis through superoxide anion-mediated Bcl-2 degradation. Chanvorachote P, Pongrakhananon V, Wannachaiyasit S, Luanpitpong S, Rojanasakul Y, Nimmannit U. Cancer Invest; 2009 Jul 15; 27(6):624-35. PubMed ID: 19283527 [Abstract] [Full Text] [Related]
16. Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101). Tsuchiya R, Suzuki K, Ichinose Y, Watanabe Y, Yasumitsu T, Ishizuka N, Kato H. J Thorac Cardiovasc Surg; 2005 May 15; 129(5):977-83. PubMed ID: 15867769 [Abstract] [Full Text] [Related]
17. Role of mitochondria in quercetin-enhanced chemotherapeutic response in human non-small cell lung carcinoma H-520 cells. Kuhar M, Sen S, Singh N. Anticancer Res; 2006 May 15; 26(2A):1297-303. PubMed ID: 16619537 [Abstract] [Full Text] [Related]
18. Tumour stage, node stage, p53 gene status, and bcl-2 protein expression as predictors of tumour response to platin-fluorouracil chemotherapy in patients with squamous-cell carcinoma of the head and neck. Fouret P, Temam S, Charlotte F, Lacau-St-Guily J. Br J Cancer; 2002 Dec 02; 87(12):1390-5. PubMed ID: 12454767 [Abstract] [Full Text] [Related]
19. Growing clinical evidence for the interaction of the p53 genotype and response to induction chemotherapy in advanced non-small cell lung cancer. Kandioler D, Stamatis G, Eberhardt W, Kappel S, Zöchbauer-Müller S, Kührer I, Mittlböck M, Zwrtek R, Aigner C, Bichler C, Tichy V, Hudec M, Bachleitner T, End A, Müller MR, Roth E, Klepetko W. J Thorac Cardiovasc Surg; 2008 May 02; 135(5):1036-41. PubMed ID: 18455581 [Abstract] [Full Text] [Related]
20. Apoptotic markers p53, Bcl-2 and Bax in primary lung cancer. Porebska I, Wyrodek E, Kosacka M, Adamiak J, Jankowska R, Harłozińska-Szmyrka A. In Vivo; 2006 May 02; 20(5):599-604. PubMed ID: 17091766 [Abstract] [Full Text] [Related] Page: [Next] [New Search]